Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Pharmacogenetics and schizophrenia.

Foster A, Miller DD, Buckley P.

Clin Lab Med. 2010 Dec;30(4):975-93. doi: 10.1016/j.cll.2010.07.010. Review.

PMID:
20832661
[PubMed - indexed for MEDLINE]
2.

Pharmacogenetics and schizophrenia.

Foster A, Miller DD, Buckley PF.

Psychiatr Clin North Am. 2007 Sep;30(3):417-35. Review.

PMID:
17720030
[PubMed - indexed for MEDLINE]
3.

Pharmacogenomics in schizophrenia: the quest for individualized therapy.

Basile VS, Masellis M, Potkin SG, Kennedy JL.

Hum Mol Genet. 2002 Oct 1;11(20):2517-30. Review.

PMID:
12351588
[PubMed - indexed for MEDLINE]
Free Article
4.

Personalized antipsychotic treatment: the adverse effects perspectives.

Plesnicar BK.

Psychiatr Danub. 2010 Jun;22(2):329-34. Review.

PMID:
20562775
[PubMed - indexed for MEDLINE]
Free Article
5.

The impact of pharmacogenetics on the development and use of antipsychotic drugs.

Reynolds GP.

Drug Discov Today. 2007 Nov;12(21-22):953-9. Epub 2007 Sep 4. Review.

PMID:
17993414
[PubMed - indexed for MEDLINE]
6.

Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy.

Mihaljević-Peles A, Sagud M, Bozina N, Zivković M, Jovanović N.

Psychiatr Danub. 2010 Jun;22(2):335-7.

PMID:
20562776
[PubMed - indexed for MEDLINE]
Free Article
7.

Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.

Arranz MJ, de Leon J.

Mol Psychiatry. 2007 Aug;12(8):707-47. Epub 2007 Jun 5. Review.

PMID:
17549063
[PubMed - indexed for MEDLINE]
8.

Understanding the new and evolving profile of adverse drug effects in schizophrenia.

Wirshing DA, Pierre JM, Erhart SM, Boyd JA.

Psychiatr Clin North Am. 2003 Mar;26(1):165-90. Review.

PMID:
12683265
[PubMed - indexed for MEDLINE]
9.

Pharmacogenetics of schizophrenia.

Reynolds GP, Templeman LA, Godlewska BR.

Expert Opin Pharmacother. 2006 Aug;7(11):1429-40. Review.

PMID:
16859426
[PubMed - indexed for MEDLINE]
10.

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.

Masellis M, Basile VS, Ozdemir V, Meltzer HY, Macciardi FM, Kennedy JL.

Biol Psychiatry. 2000 Feb 1;47(3):252-66. Review.

PMID:
10682223
[PubMed - indexed for MEDLINE]
11.

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.

Tandon R, Belmaker RH, Gattaz WF, Lopez-Ibor JJ Jr, Okasha A, Singh B, Stein DJ, Olie JP, Fleischhacker WW, Moeller HJ; Section of Pharmacopsychiatry, World Psychiatric Association.

Schizophr Res. 2008 Mar;100(1-3):20-38. doi: 10.1016/j.schres.2007.11.033. Epub 2008 Feb 19. Review.

PMID:
18243663
[PubMed - indexed for MEDLINE]
12.

Pharmacogenetics of antipsychotics: recent progress and methodological issues.

Zhang JP, Malhotra AK.

Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):183-91. doi: 10.1517/17425255.2013.736964. Epub 2012 Dec 1. Review.

PMID:
23199282
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Pharmacogenomics can improve antipsychotic treatment in schizophrenia.

Xu Q, Wu X, Xiong Y, Xing Q, He L, Qin S.

Front Med. 2013 Jun;7(2):180-90. doi: 10.1007/s11684-013-0249-3. Epub 2013 Apr 21. Review.

PMID:
23606027
[PubMed - indexed for MEDLINE]
14.

[Pharmacogenetics of antipsychotics in schizophrenia].

Méary A.

Therapie. 2008 May-Jun;63(3):243-6. doi: 10.2515/therapie:2008033. Epub 2008 Aug 23. Review. French.

PMID:
18718213
[PubMed - indexed for MEDLINE]
15.

Pharmacogenetics of psychotropic drug response.

Malhotra AK, Murphy GM Jr, Kennedy JL.

Am J Psychiatry. 2004 May;161(5):780-96. Review.

PMID:
15121641
[PubMed - indexed for MEDLINE]
16.

Pharmacogenetics as a tool in the therapy of schizophrenia.

Wilffert B, Zaal R, Brouwers JR.

Pharm World Sci. 2005 Feb;27(1):20-30. Review. Erratum in: Pharm World Sci. 2005 Jun;27(3):267.

PMID:
15861931
[PubMed - indexed for MEDLINE]
17.

Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.

Zhang JP, Malhotra AK.

Expert Opin Drug Metab Toxicol. 2011 Jan;7(1):9-37. doi: 10.1517/17425255.2011.532787. Review.

PMID:
21162693
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial.

Weiden PJ.

J Clin Psychiatry. 2007;68 Suppl 1:12-9.

PMID:
17286523
[PubMed - indexed for MEDLINE]
19.

Pharmacogenetic approaches to cognitive enhancement in schizophrenia.

Burdick KE, Gopin CB, Malhotra AK.

Harv Rev Psychiatry. 2011 May-Jun;19(3):102-8. doi: 10.3109/10673229.2011.581899. Review.

PMID:
21631157
[PubMed - indexed for MEDLINE]
20.

The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.

Reynolds GP, Templeman LA, Zhang ZJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):1021-8. Review.

PMID:
15953671
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk